Medical care expenditures associated with chronic kidney disease in adults with diabetes: United States 2011
- PMID: 25935258
- PMCID: PMC7518639
- DOI: 10.1016/j.diabres.2015.04.011
Medical care expenditures associated with chronic kidney disease in adults with diabetes: United States 2011
Abstract
Objective: Approximately 1 in 3 adults with diabetes have CKD. However, there are no recent national estimates of the association of CKD with medical care expenditures in individuals with diabetes. Our aim is to assess the association of CKD with total medical expenditures in US adults with diabetes using a national sample and novel cost estimation methodology.
Research design and methods: Data on 2,053 adults with diabetes in the 2011 Medical Expenditure Panel Survey (MEPS) was analyzed. Individuals with CKD were identified based on self-report. Adjusted mean health services expenditures per person in 2011 were estimated using a two-part model after adjusting for demographic and clinical covariates.
Results: Of the 2,053 individuals with diabetes, approximately 9.7% had self-reported CKD. Unadjusted mean expenditures for individuals with CKD were $20,726 relative to $9,689.49 for no CKD. Adjusted mean expenditures from the 2-part model for individuals with CKD were $8473 higher relative to individuals without CKD. Additional significant covariates were Hispanic/other race, uninsured, urban dwellers, CVD, stroke, high cholesterol, arthritis, and asthma. The estimated unadjusted total expenditures for individuals with CKD were estimated to be in excess of $43 billion in 2011.
Conclusions: We showed that CKD is a significant contributor to the financial burden among individuals with diabetes, and that minorities and the uninsured with CKD may experience barriers in access to care. Our study also provides a baseline national estimate of CKD cost in Diabetes by which future studies can be used for comparison.
Keywords: Chronic kidney disease; Cost; Diabetes; MEPS.
Published by Elsevier Ireland Ltd.
Conflict of interest statement
Conflicts of interest statement
The authors report no potential conflicts of interest relevant to this article.
Similar articles
-
Trends in healthcare expenditure in United States adults with chronic kidney disease: 2002-2011.BMC Health Serv Res. 2017 May 22;17(1):368. doi: 10.1186/s12913-017-2303-3. BMC Health Serv Res. 2017. PMID: 28532412 Free PMC article.
-
Non-dialysis dependent chronic kidney disease is associated with high total and out-of-pocket healthcare expenditures.BMC Nephrol. 2017 Jan 5;18(1):3. doi: 10.1186/s12882-016-0432-2. BMC Nephrol. 2017. PMID: 28056852 Free PMC article.
-
Medical costs associated with chronic kidney disease progression in an Asian population with type 2 diabetes mellitus.Nephrology (Carlton). 2019 May;24(5):534-541. doi: 10.1111/nep.13478. Nephrology (Carlton). 2019. PMID: 30141833
-
Economic costs of diabetes in the U.S. In 2007.Diabetes Care. 2008 Mar;31(3):596-615. doi: 10.2337/dc08-9017. Diabetes Care. 2008. PMID: 18308683 Review.
-
Health Expenditures for Adults by Number of Treated Chronic Conditions, Race/Ethnicity, and Age, 2012.2015 Dec. In: Statistical Brief (Medical Expenditure Panel Survey (US)) [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2001–. STATISTICAL BRIEF #485. 2015 Dec. In: Statistical Brief (Medical Expenditure Panel Survey (US)) [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2001–. STATISTICAL BRIEF #485. PMID: 28783271 Free Books & Documents. Review.
Cited by
-
Rationale and design of the Innsbruck Diabetic Kidney Disease Cohort (IDKDC)-a prospective study investigating etiology and progression of early-stage chronic kidney disease in type 2 diabetes.Clin Kidney J. 2024 Apr 11;17(5):sfae109. doi: 10.1093/ckj/sfae109. eCollection 2024 May. Clin Kidney J. 2024. PMID: 38726211 Free PMC article.
-
Humanistic and Economic Burden of Patients with Cardiorenal Metabolic Conditions: A Systematic Review.Diabetes Ther. 2023 Dec;14(12):1979-1996. doi: 10.1007/s13300-023-01464-8. Epub 2023 Sep 26. Diabetes Ther. 2023. PMID: 37751142 Free PMC article. Review.
-
Healthcare costs associated with comorbid cardiovascular and renal conditions among persons with diabetes, 2008-2019.Diabetol Metab Syndr. 2022 Nov 28;14(1):179. doi: 10.1186/s13098-022-00957-z. Diabetol Metab Syndr. 2022. PMID: 36443803 Free PMC article.
-
The Economic Burden of Chronic Kidney Disease in Vietnam.Health Serv Insights. 2021 Jul 28;14:11786329211036011. doi: 10.1177/11786329211036011. eCollection 2021. Health Serv Insights. 2021. PMID: 34376990 Free PMC article.
-
Empagliflozin Inhibits Basal and IL-1β-Mediated MCP-1/CCL2 and Endothelin-1 Expression in Human Proximal Tubular Cells.Int J Mol Sci. 2020 Nov 1;21(21):8189. doi: 10.3390/ijms21218189. Int J Mol Sci. 2020. PMID: 33139635 Free PMC article.
References
-
- Guariguata L, Whiting DR, Beagley J, et al. Global estimates of diabetes prevalence in adults for 2013 and projections for 2035 for the IDF Diabetes Atlas. Diabetes Res Clin Pract 2014;103(2):137–49. - PubMed
-
- Centers for Disease Control and Prevention. National diabetes statistics report: estimates of diabetes and its burden in the United States, 2014. Atlanta: U.S. Department of Health and Human Services; 2014.
-
- Centers for Disease Control and Prevention (CDC). National chronic kidney disease fact sheet: general information and national estimates on chronic kidney disease in the United States, 2014. Atlanta: US Department of Health and Human Services, Centers for Disease Control and Prevention; 2014.
-
- Rao C, Adair T, Bain C, et al. Mortality from diabetic renal disease: a hidden epidemic. Eur J Public Health 2012;22: 280–4. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
